期刊文献+

阿司匹林和氯吡格雷抵抗的处理对策 被引量:3

Aspirin and Clopidogrel Resistance in Response to Treatment
下载PDF
导出
摘要 阿司匹林和氯吡格雷是临床上应用最广泛的抗血小板聚集药物,但有些患者接受抗血小板聚集药物治疗,仍有心肌梗死、猝死等不良事件发生。因此,正确识别、及时处理其抵抗具有重要的临床意义。现就对阿司匹林和氯吡格雷抵抗的定义,检测方法,处理对策做一综述。 Aspirin and clopidogrel are the most widely used anti-platelet drugs in the clinical setting. However, myocardial infarction and sudden death still occur in patients taking anti-platelet drugs. Therefore it is important to recognize and deal with resistance of anti-plate- let drugs in the clinic. In this article we have summarized the definition, detection methods and treatment of adverse cardiac events with aspirin and clopidogrel.
出处 《心血管病学进展》 CAS 2010年第2期286-288,共3页 Advances in Cardiovascular Diseases
关键词 阿司匹林 氯吡格雷 抵抗 处理对策 aspirin clopidogrel resistance treatment measures
  • 相关文献

参考文献17

  • 1Bhatt DL. Aspirin resistance:more than just a laboratory curiosity [ J ]. J Am Coll Cardiol, 2004,43 ( 6 ) : 1127-1129.
  • 2Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin[ J]. N Engl J Med ,2001 ,345:1809-1817.
  • 3Lev EI,Patel RT,Mares KJ,et al. Aspirin and clopidogrel drug response in patients undergoing pevcutaneous coronary intervention :the role of dual drug resistance [ J ]. J Am Coll Cardiol,2006 ,47 ( 1 ) : 163-169.
  • 4Feuring M,Schultz A,Losel R,et al. Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-loo [ J ]. Semin Thromb Haemost, 2005,31(4) :411-415.
  • 5Laurent B,Laurence CJ. Adjusted clopidogrel loading doses according to vasodilator-stimalated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance[ J ]. J Am Coil Cardiol,2008,51 (14) : 1404-1411.
  • 6Mobley JE,Bresee SJ,Wortham DC,et al. Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization [ J ]. Am J Cardiol,2004,93 (4) :456-458.
  • 7Gurbel PA, Bliden KP. Hiatt BL, et al. Clopidogrel for coronary stcnting: response variability drug resistance and the effect of pretreatment platelet reactivity [ J ]. Circulation, 2003,107 ( 23 ) : 2908 -2913.
  • 8Serebruany VL,Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals[ J ]. J Am Coll Cardiol,2005,45 (2) : 246-251.
  • 9Patti G, Colonna G, Pasceri V, et al. Randomized trim of high loading dose of clopidogrel for reduction of periprocedural mycardial infarction in patients undergoing coronary, intervention. Results from the ARMY-DA-22 (antiplatelet therapy for reduction of myocardial damage during angioplasty ) Study [ J ]. Circulation,2005,111 (16) :2099.
  • 10Cuisset T, Frere C, Quilici J,et al. Benefit of a 600mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting [ J ]. J Am Coll Cardiol,2006,48 : 1339-1345.

共引文献27

同被引文献16

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部